Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Nancy Hunter

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Chemicals & Drugs

Disorders

Procedures

Physiology

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Wiedenmann Nicole; Valdecanas David; Hunter Nancy; Hyde Stephen; Buchholz Thomas A; Milas Luka; Mason Kathryn A
130-nm albumin-bound paclitaxel enhances tumor radiocurability and therapeutic gain.
Itasaka Satoshi; Komaki Ritsuko; Herbst Roy S; Shibuya Keiko; Shintani Tomoaki; Hunter Nancy R; Onn Amir; Bucana Corazon D; Milas Luka; Ang K Kian; O'Reilly Michael S
Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice.
Milas Luka; Fang Fu-Min; Mason Kathy A; Valdecanas David; Hunter Nancy; Koto Masashi; Ang K Kian
Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Nancy Hunter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2007: Wiedenmann Nicole; Valdecanas David; Hunter Nancy; Hyde Stephen; Buchholz Thomas A; Milas Luka; Mason Kathryn A
130-nm albumin-bound paclitaxel enhances tumor radiocurability and therapeutic gain.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(6):1868-74.
2007: Itasaka Satoshi; Komaki Ritsuko; Herbst Roy S; Shibuya Keiko; Shintani Tomoaki; Hunter Nancy R; Onn Amir; Bucana Corazon D; Milas Luka; Ang K Kian; O'Reilly Michael S
Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice.
International journal of radiation oncology, biology, physics 2007;67(3):870-8.
2007: Milas Luka; Fang Fu-Min; Mason Kathy A; Valdecanas David; Hunter Nancy; Koto Masashi; Ang K Kian
Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation.
International journal of radiation oncology, biology, physics 2007;67(2):568-72.
2006: Mason Kathryn A; Neal Robert; Hunter Nancy; Ariga Hisanori; Ang Kian; Milas Luka
CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumors.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(2):192-8.
2005: Mason Kathryn A; Ariga Hisanori; Neal Robert; Valdecanas David; Hunter Nancy; Krieg Arthur M; Whisnant John K; Milas Luka
Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):361-9.
2004: Milas Luka; Mason Kathryn A; Ariga Hisanori; Hunter Nancy; Neal Robert; Valdecanas David; Krieg Arthur M; Whisnant John K
CpG oligodeoxynucleotide enhances tumor response to radiation.
Cancer research 2004;64(15):5074-7.
2004: Mason Kathy A; Hunter Nancy R; Raju Uma; Ariga Hisanori; Husain Amir; Valdecanas David; Neal Robert; Ang Kian K; Milas Luka
Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.
International journal of radiation oncology, biology, physics 2004;59(4):1181-9.
2004: Nakata Eiko; Hunter Nancy; Mason Kathy; Fan Zhen; Ang K Kian; Milas Luka
C225 antiepidermal growth factor receptor antibody enhances the efficacy of docetaxel chemoradiotherapy.
International journal of radiation oncology, biology, physics 2004;59(4):1163-73.
2004: Nakata Eiko; Mason Kathryn A; Hunter Nancy; Husain Amir; Raju Uma; Liao Zhongxing; Ang Kian K; Milas Luka
Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors.
International journal of radiation oncology, biology, physics 2004;58(2):369-75.
2003: Liang Ke; Ang K Kian; Milas Luka; Hunter Nancy; Fan Zhen
The epidermal growth factor receptor mediates radioresistance.
International journal of radiation oncology, biology, physics 2003;57(1):246-54.
2003: Milas Luka; Mason Kathryn A; Hunter Nancy; Li Chun; Wallace Sidney
Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability.
International journal of radiation oncology, biology, physics 2003;55(3):707-12.
2002: Milas Luka; Akimoto Tetsuo; Hunter Nancy R; Mason Kathyrn A; Buchmiller Lara; Yamakawa Michitaka; Muramatsu Hiroyuki; Ang K Kian
Relationship between cyclin D1 expression and poor radioresponse of murine carcinomas.
International journal of radiation oncology, biology, physics 2002;52(2):514-21.
2001: Mason K; Staab A; Hunter N; McBride W; Petersen S; Terry N; Milas L
Enhancement of tumor radioresponse by docetaxel: Involvement of immune system.
International journal of oncology 2001;18(3):599-606.
2000: Li C; Ke S; Wu Q P; Tansey W; Hunter N; Buchmiller L M; Milas L; Charnsangavej C; Wallace S
Potentiation of ovarian OCa-1 tumor radioresponse by poly (L-glutamic acid)-paclitaxel conjugate.
International journal of radiation oncology, biology, physics 2000;48(4):1119-26.
2000: Li C; Ke S; Wu Q P; Tansey W; Hunter N; Buchmiller L M; Milas L; Charnsangavej C; Wallace S
Tumor irradiation enhances the tumor-specific distribution of poly(L-glutamic acid)-conjugated paclitaxel and its antitumor efficacy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(7):2829-34.
2000: Kishi K; Petersen S; Petersen C; Hunter N; Mason K; Masferrer J L; Tofilon P J; Milas L
Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor.
Cancer research 2000;60(5):1326-31.
2000: Oriuchi N; Jibu T; Milas L; Choe J; Kuang L; Kim E E; Hunter N R; Wallace S; Podoloff D A
Assessment of resistance to paclitaxel of murine tumors by (99m)Tc-MIBI/(201)Tl dual-radionuclide imaging.
Nuclear medicine and biology 2000;27(2):127-33.
2000: Milas L; Mason K; Hunter N; Petersen S; Yamakawa M; Ang K; Mendelsohn J; Fan Z
In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(2):701-8.
1999: Mason K A; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L
Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(12):4191-8.
1999: Akimoto T; Hunter N R; Buchmiller L; Mason K; Ang K K; Milas L
Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10):2884-90.
1999: Milas L; Kishi K; Hunter N; Mason K; Masferrer J L; Tofilon P J
Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme.
Journal of the National Cancer Institute 1999;91(17):1501-4.
1999: Mason K A; Milas L; Hunter N R; Elshaikh M; Buchmiller L; Kishi K; Hittelman K; Ang K K
Maximizing therapeutic gain with gemcitabine and fractionated radiation.
International journal of radiation oncology, biology, physics 1999;44(5):1125-35.
1999: Inoue T; Li C; Yang D J; Higuchi T; Oriuchi N; Yu D; Milas L; Hunter N; Wallace S; Kim E E; Podoloff D A
Evaluation of In-111 DTPA-paclitaxel scintigraphy to predict response on murine tumors to paclitaxel.
Annals of nuclear medicine 1999;13(3):169-74.
1999: Akimoto T; Seong J; Hunter N R; Buchmiller L; Mason K; Milas L
Association of increased radiocurability of murine carcinomas with low constitutive expression of p21(WAF1/CIP1) protein.
International journal of radiation oncology, biology, physics 1999;44(2):413-9.
1999: Li C; Price J E; Milas L; Hunter N R; Ke S; Yu D F; Charnsangavej C; Wallace S
Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(4):891-7.
1999: Milas L; Fujii T; Hunter N; Elshaikh M; Mason K; Plunkett W; Ang K K; Hittelman W
Enhancement of tumor radioresponse in vivo by gemcitabine.
Cancer research 1999;59(1):107-14.
1998: Li C; Yu D F; Newman R A; Cabral F; Stephens L C; Hunter N; Milas L; Wallace S
Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate.
Cancer research 1998;58(11):2404-9.
1997: Mason K A; Hunter N R; Milas M; Abbruzzese J L; Milas L
Docetaxel enhances tumor radioresponse in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 1):2431-8.
1997: Milross C G; Mason K A; Hunter N R; Terry N H; Patel N; Harada S; Jibu T; Seong J; Milas L
Enhanced radioresponse of paclitaxel-sensitive and -resistant tumours in vivo.
European journal of cancer (Oxford, England : 1990) 1997;33(8):1299-308.
1997: Li C; Yu D F; Inoue T; Yang D J; Tansey W; Liu C W; Milas L; Hunter N R; Kim E E; Wallace S
Synthesis, biodistribution and imaging properties of indium-111-DTPA-paclitaxel in mice bearing mammary tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(7):1042-7.
1997: Seong J; Milross C G; Hunter N R; Shin H C; Milas L
Potentiation of antitumor efficacy of paclitaxel by recombinant tumor necrosis factor-alpha.
Anti-cancer drugs 1997;8(1):80-7.
1997: Milas L; Gregoire V; Hunter N; Kurdoglu B; Mason K; Meyn R
Radiation-induced apoptosis in tumors: effect of radiation modulating agents.
Advances in experimental medicine and biology 1997;400B():559-64.
1997: Milross C G; Tucker S L; Mason K A; Hunter N R; Peters L J; Milas L
The effect of tumor size on necrosis and polarographically measured pO2.
Acta oncologica (Stockholm, Sweden) 1997;36(2):183-9.
1996: Inoue T; Yang D J; Wallace S; Cherif A; Tansey W; Kim E E; Hunter N; Milross C G; Milas L; Podoloff D A
Evaluation of [131I]iodoerythronitroimidazole as a predictor for the radiosensitizing effect.
Anti-cancer drugs 1996;7(8):858-65.
1996: Grégoire V; Hunter N R; Brock W A; Hittelman W N; Plunkett W; Milas L
Improvement in the therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus fludarabine.
Radiation research 1996;146(5):548-53.
1996: Milross C G; Mason K A; Hunter N R; Chung W K; Peters L J; Milas L
Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel.
Journal of the National Cancer Institute 1996;88(18):1308-14.
1996: Li C; Yu D; Inoue T; Yang D J; Milas L; Hunter N R; Kim E E; Wallace S
Synthesis and evaluation of water-soluble polyethylene glycol-paclitaxel conjugate as a paclitaxel prodrug.
Anti-cancer drugs 1996;7(6):642-8.
1996: Milas L; Saito Y; Hunter N; Milross C G; Mason K A
Therapeutic potential of paclitaxel-radiation treatment of a murine ovarian carcinoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;40(2):163-70.
1996: Thames H D; Ruifrok A C; Milas L; Hunter N; Mason K A; Terry N H; White R A
Accelerated repopulation during fractionated irradiation of a murine ovarian carcinoma: downregulation of apoptosis as a possible mechanism.
International journal of radiation oncology, biology, physics 1996;35(5):951-62.
1995: Milross C G; Peters L J; Hunter N R; Mason K A; Milas L
Sequence-dependent antitumor activity of paclitaxel (taxol) and cisplatin in vivo.
International journal of cancer. Journal international du cancer 1995;62(5):599-604.
1995: Milas L; Hunter N R; Mason K A; Milross C G; Saito Y; Peters L J
Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel.
Cancer research 1995;55(16):3564-8.
1995: Meyn R E; Stephens L C; Hunter N R; Milas L
Apoptosis in murine tumors treated with chemotherapy agents.
Anti-cancer drugs 1995;6(3):443-50.
1995: Meyn R E; Stephens L C; Hunter N R; Milas L
Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas.
International journal of cancer. Journal international du cancer 1995;60(5):725-9.
1995: Milas L; Hunter N R; Kurdoglu B; Mason K A; Meyn R E; Stephens L C; Peters L J
Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol.
Cancer chemotherapy and pharmacology 1995;35(4):297-303.
1995: Milas L; Hunter N; Mason K A; Milross C; Peters L J
Tumor reoxygenation as a mechanism of taxol-induced enhancement of tumor radioresponse.
Acta oncologica (Stockholm, Sweden) 1995;34(3):409-12.
1994: Meyn R E; Stephens L C; Hunter N R; Ang K K; Milas L
Reemergence of apoptotic cells between fractionated doses in irradiated murine tumors.
International journal of radiation oncology, biology, physics 1994;30(3):619-24.
1994: Ruifrok A C; Mason K A; Hunter N; Thames H D
Changes in the radiation sensitivity of mouse skin during fractionated and prolonged treatments.
Radiation research 1994;139(3):334-43.
1994: Grégoire V; Hunter N; Brock W A; Milas L; Plunkett W; Hittelman W N
Fludarabine improves the therapeutic ratio of radiotherapy in mouse tumors after single-dose irradiation.
International journal of radiation oncology, biology, physics 1994;30(2):363-71.
1994: Milas L; Hunter N R; Mason K A; Kurdoglu B; Peters L J
Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel.
Cancer research 1994;54(13):3506-10.
1994: Milas L; Nakayama T; Hunter N; Jones S; Lin T M; Yamada S; Thames H; Peters L
Dynamics of tumor cell clonogen repopulation in a murine sarcoma treated with cyclophosphamide.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;30(3):247-53.
1994: Grégoire V; Hunter N; Milas L; Brock W A; Plunkett W; Hittelman W N
Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine.
Cancer research 1994;54(2):468-74.
1994: Meyn R E; Stephens L C; Hunter N R; Milas L
Induction of apoptosis in murine tumors by cyclophosphamide.
Cancer chemotherapy and pharmacology 1994;33(5):410-4.
1993: Meyn R E; Stephens L C; Ang K K; Hunter N R; Brock W A; Milas L; Peters L J
Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies.
International journal of radiation biology 1993;64(5):583-91.
1993: Besa P C; Hunter N R; Milas L
Improvement in radiotherapy for a murine sarcoma by indomethacin plus WR-2721.
Radiation research 1993;135(1):93-7.
1993: Stephens L C; Hunter N R; Ang K K; Milas L; Meyn R E
Development of apoptosis in irradiated murine tumors as a function of time and dose.
Radiation research 1993;135(1):75-80.
1992: Hunter N; Nakayama T; Ito H; Woo S; Milas L
Combination of interleukin-2 and irradiation in therapy of murine tumors.
Clinical & experimental metastasis 1992;10(6):431-6.
1992: Milas L; Nishiguchi I; Hunter N; Murray D; Fleck R; Ito H; Travis E
Radiation protection against early and late effects of ionizing irradiation by the prostaglandin inhibitor indomethacin.
Advances in space research : the official journal of the Committee on Space Research (COSPAR) 1992;12(2-3):265-71.
1992: Hunter N R; Guttenberger R; Milas L
Modification of radiation-induced carcinogenesis in mice by misonidazole and WR-2721.
International journal of radiation oncology, biology, physics 1992;22(4):795-8.
1991: Milas L; Yamada S; Hunter N; Guttenberger R; Thames H D
Changes in TCD50 as a measure of clonogen doubling time in irradiated and unirradiated tumors.
International journal of radiation oncology, biology, physics 1991;21(5):1195-202.
1991: Milas L; Ito H; Nakayama T; Hunter N
Improvement in therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus misonidazole.
Cancer research 1991;51(14):3639-42.
1991: Milas L; Hunter N; Furuta Y; Nishiguchi I; Runkel S
Antitumour effects of indomethacin alone and in combination with radiotherapy: role of inhibition of tumour angiogenesis.
International journal of radiation biology 1991;60(1-2):65-70.
1991: Runkel S; Hunter N; Milas L
An intradermal assay for quantification and kinetics studies of tumor angiogenesis in mice.
Radiation research 1991;126(2):237-43.
1991: Tucker S L; Thames H D; Brown B W; Mason K A; Hunter N R; Withers H R
Direct analyses of in vivo colony survival after single and fractionated doses of radiation.
International journal of radiation biology 1991;59(3):777-95.
1990: Milas L; Furuta Y; Hunter N; Nishiguchi I; Runkel S
Dependence of indomethacin-induced potentiation of murine tumor radioresponse on tumor host immunocompetence.
Cancer research 1990;50(15):4473-7.
1990: Nishiguchi I; Furuta Y; Hunter N; Murray D; Milas L
Radioprotection of hematopoietic tissues in mice by indomethacin.
Radiation research 1990;122(2):188-92.
1989: Murray D; Altschuler E M; Hunter N; Milas L
Protection by WR-3689 against gamma-ray-induced intestinal damage: comparative effect on clonogenic cell survival, mouse survival, and DNA damage.
Radiation research 1989;120(2):339-51.
1989: Milas L; Sersa G; Willingham V; Hunter N; Woo S
Adoptive immunotherapy as an adjunctive treatment to thoracic irradiation for pulmonary tumor deposits in mice.
Cancer research 1989;49(18):4979-82.
1988: Furuta Y; Hunter N; Barkley T; Hall E; Milas L
Increase in radioresponse of murine tumors by treatment with indomethacin.
Cancer research 1988;48(11):3008-13.
1988: Terry N H; Ang K K; Hunter N R; Milas L
Tissue repair and repopulation in the tumor bed effect.
Radiation research 1988;114(3):621-6.
1988: Milas L; Hirata H; Hunter N; Peters L J
Effect of radiation-induced injury of tumor bed stroma on metastatic spread of murine sarcomas and carcinomas.
Cancer research 1988;48(8):2116-20.
1987: Iwakawa M; Tofilon P J; Hunter N; Stephens L C; Milas L
Antitumor and antimetastatic activity of the differentiating agent N-methylformamide in murine tumor systems.
Clinical & experimental metastasis 1987;5(4):289-300.
1987: Milas L; Iwakawa M; Hunter N
Enhancement of lung colony formation by admixing irradiated with viable tumor cells: dependence on host status.
Clinical & experimental metastasis 1987;5(3):213-7.
1987: Iwakawa M; Milas L; Hunter N; Tofilon P J
Modification of tumor and normal tissue radioresponse in mice by N-methylformamide.
International journal of radiation oncology, biology, physics 1987;13(1):55-60.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Nancy Hunter

Research Profile (preview)

Living Beings

Chemicals & Drugs

Disorders

Procedures

Physiology

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Nancy Hunter (preview)

All Publications